Endo Pharmaceuticals, Inc. recalls Clonazepam Orally Disintegrating Tablets
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
- Products
-
- Clonazepam Orally Disintegrating Tablets
- Company
- Endo Pharmaceuticals, Inc.
- Where it was sold
-
Nationwide in the USA and Puerto Rico
Nationwide
- Units affected
- 8,139 cartons
- About this recall
- Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.